Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

In Vivo Eradication of a Rituximab-Resistant Human CD20 + B Cell Lymphoma by Rituximab-CpG Oligodeoxynucleotide Conjugate Is Mediated by Natural Killer Cells and Complement.

David J Betting, Kamran Kafi, Reiko E Yamada, Kristopher K Steward, Tove Olafsen, PhD, Anna M Wu, PhD, Nico van Rooijen, John M Timmerman, MD

Blood (2009) 114 (22): 723.

https://doi.org/10.1182/blood.V114.22.723.723

Published: 2009

Journal Articles

Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo

Suzanne N. Franki, Kristopher K. Steward, David J. Betting, Kamran Kafi, Reiko E. Yamada, John M. Timmerman

Blood (2008) 111 (3): 1504–1511.

https://doi.org/10.1182/blood-2007-03-080507

Published: 2008

Includes: Supplemental data

Journal Articles

Therapeutic Lymphoma Idiotype Vaccine Generated in Insect Cells Results in Mannose Receptor Targeting and Enhanced Immune Activation.

David J. Betting, MS, Xi Y. Mu, PhD, Kamran Kafi, B.S., Desmond McDonnel, Francisco Rosas, Daniel P. Gold, PhD, John M. Timmerman, M.D.

Blood (2007) 110 (11): 2343.

https://doi.org/10.1182/blood.V110.11.2343.2343

Published: 2007

Journal Articles

Superior T Cell and Humoral Immunity Generated Against B Cell Lymphomas Using a Sulfhydryl-Based Idiotype Carrier Protein Conjugation Method.

David J. Betting, MS, Kamran Kafi, B.S., Alireza Abdollahi-Fard, B.S., Sara A. Hurvitz, M.D., John M. Timmerman, M.D.

Blood (2006) 108 (11): 232.

https://doi.org/10.1182/blood.V108.11.232.232

Published: 2006

Journal Articles

Improvement of Idiotype Vaccine Efficacy Using a Sulfhydryl-Based Carrier Protein Conjugation Method: Results in Multiple Murine Lymphoma Models.

David Betting, Kamran Kafi-Tehrani, Alireza Abdollahi-Fard, Sara A. Hurvitz, MD, John M. Timmerman, MD

Blood (2005) 106 (11): 1481.

https://doi.org/10.1182/blood.V106.11.1481.1481

Published: 2005

NARROW

In Vivo Eradication of a Rituximab-Resistant Human CD20 + B Cell Lymphoma by Rituximab-CpG Oligodeoxynucleotide Conjugate Is Mediated by Natural Killer Cells and Complement.

Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo

Therapeutic Lymphoma Idiotype Vaccine Generated in Insect Cells Results in Mannose Receptor Targeting and Enhanced Immune Activation.

Superior T Cell and Humoral Immunity Generated Against B Cell Lymphomas Using a Sulfhydryl-Based Idiotype Carrier Protein Conjugation Method.

Improvement of Idiotype Vaccine Efficacy Using a Sulfhydryl-Based Carrier Protein Conjugation Method: Results in Multiple Murine Lymphoma Models.

Email alerts

ASH Publications

American Society of Hematology

In Vivo Eradication of a Rituximab-Resistant Human CD20 + B Cell Lymphoma by Rituximab-CpG Oligodeoxynucleotide Conjugate Is Mediated by Natural Killer Cells and Complement.

Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo

Therapeutic Lymphoma Idiotype Vaccine Generated in Insect Cells Results in Mannose Receptor Targeting and Enhanced Immune Activation.

Superior T Cell and Humoral Immunity Generated Against B Cell Lymphomas Using a Sulfhydryl-Based Idiotype Carrier Protein Conjugation Method.

Improvement of Idiotype Vaccine Efficacy Using a Sulfhydryl-Based Carrier Protein Conjugation Method: Results in Multiple Murine Lymphoma Models.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only